Drugs / Iododeoxyuridine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04807257 | Aug 2024 → Dec 2025 overdue | — | NanoRay Biotech Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Iododeoxyuridine | “NanoRay Biotech is developing a novel investigational therapeutic system called Auger Molecular Therapy (AMT), which consists of a drug, Iododeoxyuridine (IUdR), and a medical...” NCT04807257 ↗ |
| Known as | IUdR | “AMT is a combination therapy of a drug (IUdR) and a device (AUTRON Therapy System).” NCT04807257 ↗ |